Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [1] Genetic variation in IL28B and hepatitis C outcomes
    Muir, Andrew J.
    CYTOKINE, 2010, 52 (1-2) : 49 - 49
  • [2] Genetic variation in IL28B is associated with response to the therapy for chronic hepatitis C
    Sugiyama, Masaya
    Tanaka, Yasuhito
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 27P - 27P
  • [3] Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
    Thomas, David L.
    Thio, Chloe L.
    Martin, Maureen P.
    Qi, Ying
    Ge, Dongliang
    O'hUigin, Colm
    Kidd, Judith
    Kidd, Kenneth
    Khakoo, Salim I.
    Alexander, Graeme
    Goedert, James J.
    Kirk, Gregory D.
    Donfield, Sharyne M.
    Rosen, Hugo R.
    Tobler, Leslie H.
    Busch, Michael P.
    McHutchison, John G.
    Goldstein, David B.
    Carrington, Mary
    NATURE, 2009, 461 (7265) : 798 - U52
  • [4] Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
    David L. Thomas
    Chloe L. Thio
    Maureen P. Martin
    Ying Qi
    Dongliang Ge
    Colm O’hUigin
    Judith Kidd
    Kenneth Kidd
    Salim I. Khakoo
    Graeme Alexander
    James J. Goedert
    Gregory D. Kirk
    Sharyne M. Donfield
    Hugo R. Rosen
    Leslie H. Tobler
    Michael P. Busch
    John G. McHutchison
    David B. Goldstein
    Mary Carrington
    Nature, 2009, 461 : 798 - 801
  • [5] IL28B polymorphisms and chronic hepatitis C
    Chevaliez, S.
    Hezode, C.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (11): : 587 - 589
  • [6] The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection
    Sakhaee, Fatemeh
    Ghazanfari, Morteza
    Vaziri, Farzam
    Jamnani, Fatemeh Rahimi
    Davari, Mehdi
    Gharibzadeh, Safoora
    Fateh, Roohollah
    Abdolrahimi, Farid
    Dizaji, Shahin Pourazar
    Fateh, Abolfazl
    Siadat, Seyed Davar
    INFECTION GENETICS AND EVOLUTION, 2017, 54 : 330 - 337
  • [7] IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection
    Moghaddam, Amir
    Melum, Espen
    Reinton, Nils
    Ring-Larsen, Helmer
    Verbaan, Hans
    Bjoro, Kristian
    Dalgard, Olav
    HEPATOLOGY, 2011, 53 (03) : 746 - 754
  • [8] HEPATIC ISGS ARE ASSOCIATED WITH GENETIC VARIATION IN IL28B AND THE OUTCOME OF IFN THERAPY FOR CHRONIC HEPATITIS C
    Honda, Masao
    Sakai, Akito
    Yamashita, Tatsuya
    Nakamoto, Yasunari
    Mizukoshi, Eishiro
    Sakai, Yoshio
    Yamashita, Taro
    Nakamura, Mikiko
    Shirasaki, Takayoshi
    Horimoto, Katsuhisa
    Tanaka, Yasuhito
    Tokunaga, Katsushi
    Mizokami, Masashi
    Kaneko, Shuichi
    HEPATOLOGY, 2010, 52 (04) : 730A - 730A
  • [9] Association of IL28B polymorphisms with hepatitis C infection
    Doehring, A.
    Hofmann, W. P.
    Schlecker, C.
    Zeuzem, S.
    Geisslinger, G.
    Sarrazin, C.
    Lotsch, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 91 - 91
  • [10] IL28B and the Control of Hepatitis C Virus Infection
    Balagopal, Ashwin
    Thomas, David L.
    Thio, Chloe L.
    GASTROENTEROLOGY, 2010, 139 (06) : 1865 - 1876
12345